BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

D-Pharm Ltd. 

Kiryat Weizmann Science Park, Bldg. 7
P.O. Box 2313
Rehovot    76123  Israel
Phone: Fax:


SEARCH JOBS








 Company News
D-Pharm Ltd. Reports The Successful Interim Analysis Of Its Phase 2 Clinical Study Of THR-18 In Acute Stroke Patients Treated With The Thrombolytic Drug tPA 3/4/2014 7:13:07 AM    More...
D-Pharm Ltd. Completes Recruitment Of Patients Into The First Dosage Tier Of Its Phase 2 Study With THR-18 In Acute Stroke Patients Treated With tPA. 1/21/2014 10:43:10 AM    More...
D-Pharm Ltd. Announces Recruitment Of The First Patient Into Its Phase 2 Clinical Trial With DP-B99 In Acute High-Risk Pancreatitis 1/14/2014 9:58:59 AM    More...
D-Pharm Ltd. Reports Enrollment Of First Patient Into Phase 2 Study Of THR-18 In Stroke Patients Treated With Tissue Plasminogen Activator (tPA) 1/2/2014 9:03:53 AM    More...
D-Pharm Ltd. Granted Patent in US and China for its Phase 2 Product THR-18 10/30/2013 10:56:41 AM    More...
D-Pharm Ltd. Commences Phase 2 Study With THR-18 in Stroke Patients Treated With Tissue Plasminogen Activator (tPA) 10/16/2013 6:55:14 AM    More...
D-Pharm Ltd. Schedules Investigators Meeting to Discuss Protocol of Phase 2 Clinical Study of DP-b99 for Acute High-Risk Pancreatitis 10/14/2013 9:18:50 AM    More...
Positive Results for D-Pharm Ltd.'s Investigational Drugs in Models of Human African Trypanosomiasis and Malaria 8/20/2013 9:10:34 AM    More...
Thrombotech Ltd. to Merge with D-Pharm Ltd. 5/24/2012 12:36:14 PM    More...
D-Pharm Ltd. Receives First Payment for Epilepsy Drug, DP-VPA From Its Chinese Partner 5/3/2012 12:27:25 PM    More...
12345

//-->